Sweetwater Resources, Inc. (OTCBB:SWTR) reached up 14.75% in morning trading to $.35 with 340K shares traded. Sweetwater has acquired certain assets to fully commercialize a proprietary, cost-efficient and high-volume diamond production method to provide industrial quality diamonds. The Company's patented technology enables the production of "cultured" diamonds that are chemically, atomically, and structurally identical to natural diamonds. Sweetwater Resources, Inc. (SWTR) yesterday announced the launch of its new corporate website located at http://www.sweetwaterresourcesinc.com. The website provides visitors with a comprehensive source of information on the Company's newly acquired diamond technology, the industry and its patents. Stakeholders can also learn about the history of the Company and its scientific team, as well as stock information and regulatory filings.
Samson Oil & Gas Limited (NYSE AMEX: SSN) reached up 8.19% in morning trading to $1.07 with 400K shares traded. Samson Oil & Gas Limited is an USA/Australian oil & gas company focusing on oil production in the Niobrara and Bakken formations in the USA. Samson Oil & Gas Limited (NYSE AMEX: SSN) yesterday provided advice on its current projects, HAWK SPRINGS PROJECT, GOSHEN COUNTY, WYOMING Spirit of America US34 #2-29, (SSN 100% WI). The Spirit of America #2 well intersected 61 feet of pay as defined by the electric logging program and its subsequent analysis. Log analysis requires several rock and fluid property assumptions and these assumptions have in part been resolved by the initial perforation and swab tests (such as the determination of the salinity of formation water). The net pay intervals so defined by these measurements and calculations will now be fracture stimulated in three stages. The initial frac will stimulate the lower perforations at around 10,000 feet, comprising 31 feet of log pay. The second stage at around 9,300 feet will stimulate a single 7 feet of log pay and the third stage at around 9,200 feet will stimulate several sandstones with 22 feet of log pay. Detailed engineering of these fracs have been completed.
Synta Pharmaceuticals Corp. (Nasdaq:SNTA) reached up 17.01% in morning trading to $5.64 with 2M shares traded. Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. Synta Pharmaceuticals Corp. (SNTA) Wednesday announced encouraging results from a planned interim analysis of the GALAXY trial, a randomized Phase 2b/3 study designed to evaluate the efficacy and safety of the Company’s lead Hsp90 inhibitor, ganetespib, in combination with standard-of-care docetaxel vs. docetaxel alone as second-line treatment for advanced non-small cell lung cancer (NSCLC).
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at email@example.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE